Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 1214 |
| Name of the vaccine | VLA1701 |
| Microbe | Bacteria |
| Disease name | E.coli Infections |
| Name of bacteria | Escherichia coli |
| Type of vaccine | NA |
| Nucleic acid content | Circular duplex DNA |
| Age | 18 to 49 years |
| Description of the vaccine | E. coli strain LSN03-016011/A. |
| Name of the manufacturer | Valneva Austria GmbH |
| Name of the manufacturing country | United States |
| Year of manufacture | 2018 |
| Clinical Phase status | Clinical - Phase 2 |
| Bacterial strain | Gram-negative, rod-shaped bacteria. |
| Efficacy | NA |
| Vaccine formulation | NA |
| Dosage | Two doses, gap of 7 days. |
| Mechanism of action | NA |
| Route of administration | Oral |
| Indications | NA |
| Export | NA |
| Approval | NA |
| Adjuvant | NA |
| Repurposing | For diarrhoea. |
| Side effects of vaccine | NA |
| Post vaccination | NA |
| Dose type | Combination (2 doses) |
| Interspecies transfer | NA |
| PubMed identifier | NA |
| Clinical trial number | NCT03576183 |
| Reference | NA |
| Other name | NA |
| Additional Links | NA |